CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety. Wekking D, Lambertini M, Dessi M, Denaro N, et al. Semin Oncol 2024 Jan 13:S0093-7754(24)00002.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wekking D, Lambertini M, Dessi M, Denaro N, et al. CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety. Semin Oncol 2024 Jan 13:S0093-7754(24)00002.
PMID: 38245458